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Theiler’s murine encephalomyelitis virus (TMEV or Theiler’s virus) is a neurotropic picornavirus that
can persist lifelong in the central nervous system of infected mice, causing a chronic inflammatory
demyelinating disease. The leader (L) protein of the virus is an important determinant of viral
persistence and has been shown to inhibit transcription of type I interferon (IFN) genes and to
cause nucleocytoplasmic redistribution of host proteins. In this study, it was shown that
expression of the L protein shuts off synthesis of the reporter proteins green fluorescent protein
and firefly luciferase, suggesting that it induces a global shut-off of host protein expression. The L
protein did not inhibit transcription or translation of the reporter genes, but blocked cellular mRNA
export from the nucleus. This activity correlated with the phosphorylation of nucleoporin 98
(Nup98), an essential component of the nuclear pore complex. In contrast, the data confirmed that
the L protein inhibited IFN expression at the transcriptional level, and showed that transcription of
other chemokine or cytokine genes was affected by the L protein. This transcriptional inhibition
correlated with inhibition of interferon regulatory factor 3 (IRF-3) dimerization. Whether inhibition
of IRF-3 dimerization and dysfunction of the nuclear pore complex are related phenomena remains
an open question. In vivo, IFN antagonism appears to be an important role of the L protein early
in infection, as a virus bearing a mutation in the zinc finger of the L protein replicated as efficiently
as the wild-type virus in type I IFN receptor-deficient mice, but had impaired fitness in IFN-
competent mice.
INTRODUCTION
Theiler’s murine encephalomyelitis virus (TMEV or
Theiler’s virus), a picornavirus in the genus Cardiovirus,
is a neurotropic virus with a striking ability to cause
persistent infections of the central nervous system (CNS) of
the mouse (Theiler & Gard, 1940) (reviewed by Brahic
et al., 2005). The genome of TMEV is a single-stranded,
positive-sense RNA molecule encoding a long polyprotein,
which is processed to yield the mature viral proteins.
TMEV encodes two proteins, L and L*, that are not
essential for replication of the virus in BHK-21 cells (Kong
& Roos, 1991; Kong et al., 1994; Michiels et al., 1997), but
that are required for persistent infection of the CNS in vivo
(Ghadge et al., 1998; van Pesch et al., 2001; van Eyll &
Michiels, 2002; Paul & Michiels, 2006). The L* protein is
translated from an additional open reading frame (ORF),
overlapping the ORF encoding the L, VP4 and VP2
moieties of the viral polyprotein (Kong & Roos, 1991).
The leader (L) protein of TMEV is a 76 aa protein cleaved
from the N-terminal end of the viral polyprotein. It
possesses a zinc finger, which has been shown to bind
divalent cations (Chen et al., 1995) and to be crucial for L
protein function in vitro and in vivo (van Pesch et al., 2001;
Delhaye et al., 2004). It has been shown that the L protein
can block the production of type I interferons (IFNs) by
infected cells and that this inhibition occurs at the
transcriptional level (van Pesch et al., 2001; van Pesch &
Michiels, 2003). The L protein of TMEV has also been
shown to interfere with the nucleocytoplasmic trafficking
of cellular proteins in infected cells (Delhaye et al., 2004)
A table showing the primers used in this study is available with the online
version of this paper.
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and to trigger the subcellular redistribution of both nuclear
and cytoplasmic cellular proteins, most notably interferon
regulatory factor-3 (IRF-3).
Encephalomyocarditis virus (EMCV), another member of
the genus Cardiovirus, encodes an L protein sharing 35%
amino acid identity with the L protein of TMEV. The EMCV
and TMEV L proteins share conserved zinc fingers and
negatively charged domains. However, the EMCV L protein
lacks the C-terminal Ser/Thr-rich domain that is conserved
in the L proteins of TMEV strains. In spite of such sequence
divergences, the L proteins of EMCV and TMEV share
antagonist activities directed against IFN production and
nucleocytoplasmic trafficking (Zoll et al., 2002; Lidsky et al.,
2006; Paul & Michiels, 2006; Porter et al., 2006; Hato et al.,
2007). In the case of EMCV, IFN production inhibition was
found to correlate with inhibition of NF-kB activation (Zoll
et al., 2002) and suppression of IRF-3 dimerization (Hato et
al., 2007). Perturbation of nucleocytoplasmic transport by
the EMCV L protein (Lidsky et al., 2006) correlated with the
interaction of this protein with Ran GTPase, a crucial
regulator of trafficking across the nuclear envelope (Porter et
al., 2006). The blockade of macromolecule transport possibly
explains the global shut-off of protein expression mediated
by the EMCV L protein (Zoll et al., 1996). Recent work
suggests that the TMEV L protein also mediates a global
shut-off of host-cell protein expression (Baida et al., 2008).
Here, we analysed the possibility that global shut-off and
inhibition of IFN gene transcription could result from a
global inhibition of cellular transcription. Contrary to this
hypothesis, our data showed that the TMEV L protein acts at
two different levels in cells. On the one hand, it blocked
global protein expression at a post-transcriptional stage, by
preventing nuclear export of cellular mRNAs. This activity
correlated with nucleoporin 98 (Nup98) hyperphosphoryla-
tion. On the other hand, it also acted at the transcriptional
level on the expression of selected cytokine and chemokine
genes by inhibiting IRF-3 dimerization. In vivo, inhibition of
the IFN pathway appears to be an important activity of the L
protein at early times of infection.
METHODS
Cells and viruses. BHK-21, BALB/3T3 and L929 cells were cultured
as described previously (van Pesch et al., 2001). TMEV derivatives
were produced by electroporation of BHK-21 cells (Michiels et al.,
1997) with genomic RNA transcribed in vitro from plasmids carrying
the corresponding cDNAs. pTMDA1 carries the genome of virus
DA1, a molecular clone of the Daniels strain of TMEV (Daniels et al.,
1952; McAllister et al., 1989; Michiels et al., 1997). Virus TM598 is a
DA1 derivative carrying mutations disrupting the zinc finger motif of
the L protein (Lcys mutation), but which do not modify the amino
acid sequence of the L* protein, which is translated from an
overlapping ORF (van Pesch et al., 2001). KJ6 is a DA1 derivative
containing capsid mutations adapting the virus to infect L929 cells
with high efficiency (Jnaoui & Michiels, 1998). The corresponding
Lcys mutant was called TM659 (van Pesch et al., 2001). SB3 is another
derivative of KJ6, which carries a deletion encompassing codons 6–67
of the L region (LD6–67). The pSB3 plasmid, carrying the genome of
this virus, was obtained by replacing, in pTM564 (Michiels et al.,
1997), an MscI–BamHI restriction fragment in the capsid-coding
region with the corresponding fragment of pKJ6.
Plasmids construction. Plasmids were constructed in the pcDNA3
vector backbone (Invitrogen), in which gene transcription is under the
control of the cytomegalovirus immediate-early promoter (PCMV). A
series of plasmids, pTM553, pTM592 and pTM641, were designed to
express the L, Lcys and LD6–67 proteins, respectively. A second series of
plasmids was designed to express a fusion protein comprising the L
protein variants and enhanced green fluorescent protein (eGFP)
(pCER01, pCER02 and pCER03). pCER03 encodes eGFP alone. In
pCER01 (Lwt) and pCER02 (Lcys), the junction between L and eGFP
encompasses codons Pro-75 and Gln-76 of the L protein, a Val-Thr
linker and codons Lys-4 and Gly-5 of eGFP. A third series of plasmids
was derived from pTM624. This vector contains PCMV, a multi-cloning
site and an internal ribosome entry site (IRES) corresponding to nt
392–1065 of TMEV (strain DA1), driving the translation of eGFP
(unpublished data). These plasmids co-express the L protein variants
and eGFP. The matrix (M) protein-coding region of vesicular
stomatitis virus (VSV) was PCR-amplified with primers TM822 and
TM823 from cDNA generated from VSV (strain Indiana)-infected
L929 cells and cloned in the pTM624 bicistronic construct. Plasmid
pCS41 is a pcDNA3 derivative expressing the firefly luciferase (luc) gene
(Sommereyns et al., 2008). Table 1 summarizes the properties of the
plasmids used in this study. Primers are presented in Supplementary
Table S1 available in JGV Online.
Capped RNA transcript synthesis. Capped luciferase mRNA was
transcribed in vitro from plasmid pCS41, using T7 RNA polymerase
(Roche) and a Ribo m7G cap analogue (0.5 mM; Promega), using the
conditions recommended by Promega. To eliminate template plasmid
DNA, the transcription reaction products were treated with DNase I as
described previously (Shaw-Jackson & Michiels, 1999). Residual
contaminating DNA amounts, measured by real-time PCR, were not
sufficient to generate detectable luciferase activity (data not shown).
DNA and RNA transfections. Plasmid DNA was transfected with
TransIT-LT1 Transfection Reagent (Mirus) according to the manu-
facturer’s recommendations. Three microlitres of transfection reagent
was used with 1 mg DNA to transfect 36105 cells grown in one well of
a 24-well plate.
RNA/DNA mixtures were transfected with the TransIT-mRNA
Transfection kit (Mirus) into BALB/3T3 cells, at a ratio of 1 : 9 or
1 : 39 (100 ng capped RNA transcript and 975 ng plasmid DNA, or
25 ng capped RNA transcript and 975 ng of plasmid DNA). One
microlitre of boost reagent was mixed with 1.5 ml transfection reagent
Table 1. Plasmids used in this study
Plasmid properties Lwt Lcys LD6–67
Virus cDNA
Wild-type capsid pTMDA1 pTM598 pTM564
Adapted to L929 cells pKJ6 pTM659 pSB3
L protein expression plasmids
PCMV–L pTM553 pTM592 pTM641






*Absence of L (LD) instead of LD6–67.
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and 1 mg nucleic acid in 50 ml Dulbecco’s modified Eagle’s medium.
After 15 min of incubation at room temperature, the mixture was
added to subconfluent cells grown in 24-well plates.
Oligo(dT) in situ hybridization (ISH). BALB/3T3 cells were cultured
on 13 mm coverslips. At 50% confluency, the cells were transfected
with plasmid DNA expressing the L protein constructs. At chosen
times after transfection, the cells were fixed for 8 min with 4%
paraformaldehyde in PBS and washed three times in PBS. The ISH
protocol was from B. M. Fontoura (Chakraborty et al., 2006). The
probe consisted of a 45mer oligo(dT), biotinylated at its 39 extremity
and purified by reverse phase chromatography (Eurogentec).
Streptavidin–Cy3 (diluted 1 : 100; Sigma) was used for detection.
Coverslips were mounted in Mowiol 4-88 (Calbiochem), 25% (w/v)
glycerol and 0.1% (w/v) diazabicyclooctane (Sigma) in 100 mM Tris/
HCl (pH 8.5). The data were analysed by conventional (Leica DM
IRB) or confocal (Zeiss Axiovert 135M equipped with a Bio-Rad
MRC1024 confocal device) fluorescent microscopy.
Western blotting for detection of IRF-3 dimerization and
Nup98 phosphorylation. To analyse IRF-3 dimerization, L929 cells
were infected for 9 h with KJ6, TM659 or SB3 virus, or were mock
infected. Proteins were extracted from the cells under non-denaturing
conditions and separated on native polyacrylamide gels as described
previously (Hato et al., 2007). For analysis of Nup98, BHK-21 cells
were infected for 12 h with KJ6 or TM659 virus, or were mock
infected. Proteins were extracted using Tx lysis buffer as described
previously (Park et al., 2008). Where indicated, 40 mg protein was
treated with 4 U calf alkaline phosphatase (Promega) in the
manufacturer’s recommended buffer for 1 h at 37 uC. Samples were
analysed by SDS-PAGE followed by Western blotting with a rat
monoclonal anti-Nup98 antibody (Sigma-Aldrich).
Mice and infections. 129/Sv type I IFN receptor-deficient (IFNAR2/2)
mice (Muller et al., 1994) were bred at the animal facility of the University
of Louvain, Belgium. 129/Sv mice were purchased from the same source
or from Charles River Laboratories. Handling of mice and experimental
procedures were conducted in accordance with national and institutional
guidelines for animal care and use. Groups of four (1 and 4 days p.i.) or
six (5 days p.i.) 3–4-week-old mice were infected by intracranial injection
of 40 ml serum-free medium containing 105 p.f.u. (129/Sv mice) or
103 p.f.u. (IFNAR2/2 mice) of virus. Control mice were injected with
40 ml serum-free culture medium. Mice were anaesthetized with xylazine
and ketamine before sacrifice for organ harvest.
Real-time quantitative RT-PCR. Total RNA preparations, reverse
transcription and real-time quantitative PCRs were performed as
described previously (Paul & Michiels, 2006). Real-time PCR
standards consisted of 10-fold dilutions of known concentrations of
plasmids carrying the sequence to be amplified: pcDNA3-IFN-b (van
Pesch et al., 2004) or genomic DNA for IFN-b, pTM410 for TMEV,
pTM849 for MCP-1, pTM793 for b-actin, pTM799 for RANTES,
pTM844 for interleukin (IL)-6, pTM842 for transforming growth
factor (TGF)-b and pCS41 for luciferase. Plasmids pTM793, pTM799,
pTM842, pTM844 and pTM849 are derivatives of pCR4-TOPO
(Invitrogen) in which the corresponding PCR fragments were cloned.
Sense and antisense primers used for IFN-b and MCP-1 amplification
were from Petro (2005) and Overbergh et al. (2003), respectively.
Primers are presented in Supplementary Table S1.
RESULTS
L protein shuts off synthesis of cellular proteins
We first confirmed L protein-mediated shut-off of protein
expression by testing reporter protein levels in BALB/3T3
cells transfected with plasmids encoding either wild-type or
mutant L–eGFP protein fusions or with plasmids encoding
bicistronic L–IRES–eGFP constructs. At 24 h post-trans-
fection, cells expressing the Lwt–eGFP fusion showed
significantly less fluorescence than cells expressing Lcys–
eGFP (5-fold) or LD–eGFP (16-fold), in a representative
triplicate experiment. The mean fluorescence of cells
transfected with the bicistronic plasmid encoding Lwt was
also more than 10-fold lower than that of cells that received
bicistronic constructs expressing Lcys or LD, confirming
inhibition of eGFP expression by the L protein (Fig. 1a).
To detect shut-off at earlier time points after transfection,
we used the more sensitive luciferase reporter system. We
co-transfected the firefly luciferase expression vector
(pCS41) and the L, Lcys or LD6–67 expression vector into
BALB/3T3 cells and assayed for luciferase activity (Fig. 1b).
Luciferase activity measured 7 h after transfection was 12-
fold lower in cells expressing L than in cells expressing Lcys
or LD6–67 (Fig. 1b). Interestingly, luciferase mRNA levels,
measured by real-time RT-PCR, varied less than 1.3-fold
between cells expressing mutated or wild-type L proteins
(Fig. 1c). We concluded that shut-off of luciferase
expression by the L protein occurred at a post-transcrip-
tional level.
L protein does not interfere with cytoplasmic
luciferase mRNA translation
To determine whether the L protein acted at the
translational level, capped luciferase mRNA was synthe-
sized in vitro and co-transfected into BALB/3T3 cells along
with plasmids encoding the Lwt, Lcys or LD6–67 protein. To
ensure that cells receiving luciferase mRNA also received
the L protein expression plasmid, luciferase mRNA and
plasmid DNA were transfected at ratios of 1 : 9 or 1 : 39.
Luciferase activity was measured at 7, 12 and 14 h post-
transfection (Fig. 1d and data not shown). No clear
inhibition of luciferase expression by the L protein was
observed at any time point in any of four independent
experiments involving two productions of capped lucifer-
ase mRNA and three different plasmid DNA preparations.
In addition, no luciferase activity inhibition occurred in
cells that were co-transfected with a 1 : 9 ratio of mRNA
encoding luciferase and L protein, respectively (data not
shown). Thus, the L protein of TMEV acted on luciferase
expression at a post-transcriptional stage, but upstream of
mRNA translation.
L protein interferes with cellular mRNA export and
promotes Nup98 phosphorylation
Porter et al. (2006) proposed that the L protein of EMCV
inhibited mRNA export from the nucleus. To examine the
effect of TMEV L protein on mRNA export in a direct
manner, we used ISH with an oligo(dT) probe to localize
the main pool of poly(A)+ RNA in cells transfected with
plasmids expressing the Lwt, Lcys or LD6267 protein or with
TMEV L inhibits mRNA export and IRF-3 dimerization
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the bicistronic plasmids co-expressing these proteins and
eGFP (Fig. 2a). As a control, we transfected pCER26, a
bicistronic construct that encodes the M protein of VSV,
which has been shown to block mRNA export (Her et al.,
1997). Non-transfected cells rarely showed nuclear reten-
tion of poly(A)+ RNA. In contrast, 17.3% of the cell
population transfected with the VSV M-expressing plasmid
exhibited a clear nuclear mRNA accumulation. Similarly,
14 and 9.3% of cells transfected with the monocistronic
(pTM533) and bicistronic (pTM625) plasmids expressing
the L protein, respectively, showed nuclear retention of
poly(A)+ RNA (Fig. 2a). In contrast, less than 2% of cells
transfected with plasmids expressing the corresponding L
protein deletion mutants (pTM641 and pTM624) exhib-
ited a nuclear signal. The cell population transfected with
plasmids expressing the Lcys mutant (pTM592 and
pTM626) exhibited a variable and intermediate phenotype.
Although the L protein and, to a lesser extent, the Lcys
mutant inhibited eGFP expression (Fig. 1a), using confocal
microscopy it was possible to detect eGFP-positive cells and
to evaluate the percentage of cells displaying nuclear
poly(A)+ RNA retention among cells that expressed the
bicistronic construct (i.e. eGFP-positive cells) (Fig. 2b, c).
Cells expressing LD (pTM624) displayed a mostly cytoplas-
mic poly(A)+ RNA staining, as typically observed in non-
transfected cells. In contrast, nearly 100% of cells expressing
the TMEV L protein (pTM625) displayed nuclear accu-
mulation of cellular poly(A)+ RNA, very similar to the
results of cells expressing the VSV M protein (pCER26).
Surprisingly, 70% of cells expressing the Lcys mutant
(pTM626) showed nuclear accumulation of cellular
poly(A)+ RNA, in spite of disruption of the zinc finger in
this mutant protein (Fig. 2b, c). This experiment showed
that the L protein of TMEV provokes nuclear retention of
cellular poly(A)+ mRNA. L protein-mediated nuclear
accumulation of mRNA became detectable from 8 h post-
transfection and increased with time (data not shown).
The VSV M protein inhibits mRNA export by forming a
complex with the transport factor Rae1 and with Nup98
(Faria et al., 2005), a component of the nuclear pore
complex thought to play a key role in mRNA export
(Powers et al., 1997). To determine whether TMEV L
protein might also target Nup98 to inhibit mRNA export,
we examined the status of Nup98 in cells infected with
TMEV encoding wild-type L or the Lcys mutant. Fig. 2(d)
showed that, at 12 h after infection with wild-type TMEV
(KJ6), a slower-migrating form of Nup98 was apparent in
cell lysates. This result was probably due to phosphoryla-
tion, as treatment with alkaline phosphatase converted
Fig. 1. Post-transcriptional shut-off of cellular protein synthesis by
the TMEV L protein. BALB/3T3 cells were transfected with
constructs encoding L, Lcys and LD. The histograms show the
means±SD of one representative experiment performed in
triplicate. (a) eGFP mean fluorescence measured by fluor-
escence-activated cell sorting (FACS), 24 h after transfection of
plasmids encoding the L–eGFP fusions or the L–IRES–eGFP
constructs. NT, non-transfected cells. (b) Luciferase activity (in
relative luciferase units, RLU) measured 7 h after co-transfection
of cells with plasmids expressing luciferase (pCS41) and L
(pTM553), Lcys (pTM592) or LD6–67 (pTM641). (c) Amount of
luciferase mRNA, measured by real-time RT-PCR in cells co-
transfected as described in (b). Values were normalized against b-
actin. Note that no effect of the L protein on b-actin mRNA levels
was detected at this time point. (d) The L protein does not affect
translation of cytoplasmic mRNA. BALB/3T3 cells were co-
transfected with capped luciferase RNA and plasmid DNA (ratio
1 : 9) encoding L (pTM533), Lcys (pTM592) or LD6–67 (pTM641).
The histogram shows luciferase activity (RLU), measured 14 h
after co-transfection.
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Nup98 to the single, faster-migrating form. Phosphory-
lation of Nup98 required a functional L protein, as
infection with the Lcys mutant (TM659) had no effect on
the migration of Nup98. These results suggested that
inhibition of mRNA export by the L protein may be
mediated by phosphorylation of Nup98.
L protein inhibits cytokine and chemokine gene
transcription
The lack of transcriptional inhibition of luciferase mRNA
reported here contrasts with the transcriptional inhibition
of type I IFN genes reported previously (van Pesch et al.,
2001; van Pesch & Michiels, 2003). To confirm IFN gene
transcription inhibition and to test whether transcriptional
inhibition might involve other genes, we compared the
mRNA levels of selected cytokine and chemokine genes in
L929 cells infected with virus expressing wild-type or
mutated L protein. We studied the transcription of two
chemokine genes: RANTES (regulated on activation
normal T cell expressed and secreted, or CCL5) and
MCP-1 (monocyte chemoattractant protein-1, or CCL2),
and of two cytokine genes: IL-6, which is pro-inflamma-
tory, and TGF-b, which is anti-inflammatory. IFN-b was
tested as a control to confirm previous data (Fig. 3). Under
the conditions used, the viruses infected more than 95% of
the cells, as measured by immunohistochemistry (data not
shown). At 9 h post-infection (p.i.), gene transcription of
Fig. 2. The L protein promotes nuclear retention of cellular poly(A)+ RNA and triggers phosphorylation of Nup98. (a) BALB/
3T3 cells were transfected with L, Lcys or LD6–67 expression plasmids (pTM553, pTM592 and pTM641, respectively) or with the
bicistronic constructs co-expressing these proteins and eGFP (pTM625, pTM626 and pTM624, respectively). The bicistronic
construct expressing VSV M protein (pCER26) was used as a control. Poly(A)+ RNA was detected by fluorescent ISH using an
oligo(dT) probe. The percentage of cells showing higher fluorescent intensity in the nucleus than in the cytoplasm at 16 h after
transfection is shown. NT, non-transfected cells. (b) The percentage of cells showing higher fluorescent intensity in the nucleus
than in the cytoplasm out of 50 eGFP-positive cells. (c) Representative ISH results in cells transfected with the bicistronic
constructs, showing eGFP fluorescence (top row) and detection of poly(A)+ RNA by ISH (bottom row; white arrows indicate
eGFP-positive cells). (d) Phosphorylation of Nup98 in cells infected with TMEV. BHK-21 cells were infected for 12 h with KJ6
or TM659 virus, or were mock infected. Lysates were prepared and analysed by SDS-PAGE and Western blotting to detect
Nup98. Phosphatase indicates whether protein extracts were treated with calf alkaline phosphatase or not.
TMEV L inhibits mRNA export and IRF-3 dimerization
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IFN-b, RANTES, IL-6, MCP-1 and TGF-b was upregulated
in cells infected with the Lcys and LD6–67 mutant viruses, but
not in cells infected with KJ6 virus expressing Lwt (Fig. 3).
However, induction levels differed strongly among the
genes analysed, being in the ranges of 3000-fold and 300-
fold for IFN-b and RANTES mRNA, respectively, and in
the ranges of 30-fold and 10-fold for IL-6 and MCP-1
mRNA, respectively. Upregulation of TGF-b transcription
was minimal.
These data suggest that, in addition to the post-transcrip-
tional effect of the L protein on mRNA nuclear export, the
L protein acts at a transcriptional level on the expression of
cytokine and chemokine genes that are typically activated
in response to viral infection. The effect was particularly
prominent in the case of IFN-b and RANTES genes, whose
transcription is strongly dependent on the IRF-3 tran-
scription factor.
L protein inhibits IRF-3 dimerization
We next analysed whether L protein-mediated transcrip-
tional inhibition of cytokine and chemokine genes could
result from inhibition of IRF-3 activation. IRF-3 dimeriza-
tion was examined in cells infected with TMEV encoding
wild-type and mutant L proteins. As shown in Fig. 4, IRF-3
dimers were detected in cells infected with the L protein
mutant viruses (Lcys or LD6–67). In contrast, IRF-3 was
almost entirely monomeric in uninfected cells or in cells
infected with virus expressing Lwt. Thus, viral infection can
trigger IRF-3 dimerization, but this dimerization is
impaired by the L protein.
Influence of L protein on mouse infection
To determine the biological relevance of L protein
functions and, in particular, the importance of IFN
Fig. 3. Influence of the TMEV L protein on the transcription of cytokine and chemokine genes. L929 cells were infected for 9 h
with 2 p.f.u. per cell of KJ6 (Lwt; filled columns), TM659 (Lcys; dark shaded columns), or SB3 (LD6–67; light shaded columns)
virus, or were left uninfected (NI; open columns). mRNA levels, detected by comparative real-time RT-PCR, were normalized
against the amount of b-actin in each sample. Histograms show the means±SD of the relative gene expression. Ratios
compared with KJ6-infected samples are shown in the case of viral RNA. Ratios compared with uninfected cells are shown for
other genes. Significant differences compared with the corresponding KJ6-infected sample are indicated as * (P,0.05) and **
(P,0.01), determined using an unpaired t-test.
Fig. 4. Inhibition of IRF-3 dimerization. L929 cells were infected
for 9 h with KJ6 (L), TM659 (Lcys) or SB3 (LD6–67) virus, or were
left uninfected (NI). Protein extracts were separated by PAGE
under non-denaturing conditions and IRF-3 dimer formation was
detected by Western blotting.
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production inhibition by the L protein, we compared the
replication of wild-type DA1 virus and the Lcys TM598
mutant in the CNS of wild-type and IFNAR2/2 129/Sv
mice (Fig. 5). As reported previously, the IFNAR2/2 mice
were extremely susceptible to TMEV infection (Fiette et al.,
1995). After inoculation of 103 p.f.u. DA1 or TM598,
IFNAR2/2 mice rarely survived more than 4 days p.i. At
this time point, viral load analysed by RT-PCR in the brain
of these mice was between 50- and 100-fold higher than in
the brain of wild-type mice, despite the fact that the wild-
type mice had been inoculated with a 100-fold higher virus
dose (Fig. 5). In IFNAR2/2 mice, the Lcys mutant virus
replicated as efficiently as the wild-type virus.
In contrast, in IFN-competent mice, mutation of the L
protein led to a 3.75-fold decrease in virus replication at day
4 p.i. (Fig. 5a, central columns). This replication difference
between the Lcys mutant virus and the wild-type virus
increased with time and became significant at 5 days p.i.
(Fig. 5a, right columns). The fact that the Lcys mutation
affected viral yield in wild-type mice but not in IFNAR2/2
mice suggested that, at least during the first days of infection,
the L protein acts to counteract the IFN-a/b response.
We next compared the abundance of IFN-b and RANTES
transcripts in the CNS of IFNAR2/2 mice 1 day after
infection with the DA1 and TM598 viruses. IFNAR2/2
mice were chosen for this analysis to minimize the effect of
cell priming by IFN and because the Lcys mutant and wild-
type viruses replicated to similar levels in these mice.
IFN-b and RANTES transcription was induced in the
brains of mice infected by both DA1 and TM598 viruses.
As discussed below, IFN-b and RANTES transcripts were
only slightly more abundant in mice infected with the
Lcys mutant than in mice infected with the wild-type virus
(6.5-fold and 2.1-fold, respectively) (Fig. 5b). Thus, the
inhibition of cytokine and chemokine gene transcription
observed in vitro was less extensive in vivo.
DISCUSSION
The L protein of TMEV can trigger a global shut-off of
protein expression. Interestingly, this global shut-off,
assessed by inhibition of eGFP and luciferase expression,
turned out to be neither transcriptional nor translational.
Instead, using ISH with an oligo(dT) probe, we showed in
a direct manner that the TMEV L protein inhibited export
of cellular poly(A)+ RNA from the nucleus. Such nuclear
retention of mRNA could result from L protein-mediated
inhibition of Ran GTPase activity (Porter et al., 2006).
Although Ran is not directly involved in mRNA export,
Ran inhibition might affect shuttling of proteins such as
Dbp5p or TAP/NXF1 (export receptor) or Aly/REF (export
adaptor) (Rodriguez et al., 2004) that mediate mRNA
export from the nucleus. However, our data revealed that
the TMEV L protein also triggered phosphorylation of
Nup98. This nucleoporin notably interacts with TAP/NXF1
and RAE1, factors involved in mRNA export (Pritchard et
al., 1999; Blevins et al., 2003). Thus, our observation that
the TMEV L protein mediates phosphorylation of Nup98
suggests another possible mechanism whereby the L
protein could inhibit mRNA export by modulating the
activity of components of the nuclear pore complex.
We previously reported that type I IFN and RANTES gene
expression were inhibited by the TMEV L protein (van
Fig. 5. Comparison of viral load and IFN-b and RANTES gene
expression in the brains of infected mice. Real-time quantitative
PCR was used to measure viral RNA or IFN-b and RANTES mRNA
in total RNA extracted from the brains of infected mice. (a)
Comparison of levels of Lwt (DA1) and Lcys (TM598) viral RNA
(means±SD) in the brains of IFNAR”/” and IFNAR+/+ mice at 4
and 5 days p.i. (b) Viral genomes, RANTES mRNA and IFN-b
mRNA levels measured in the brain of IFNAR”/” mice infected with
Lwt (DA1) or Lcys (TM598) virus, or left uninfected (NI), at 1 day p.i.
ND indicates that the cDNA copy number was under the detection
threshold (,10”4 copies per copy b-actin cDNA). **, P,0.01
(t-test).
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Pesch et al., 2001; Paul & Michiels, 2006). Here, we showed
that expression of other cytokine and chemokine genes,
including MCP-1 and IL-6, is also inhibited by the L
protein. In contrast to the post-transcriptional shut-off
described here, L protein-mediated inhibition of cytokine
and chemokine gene expression occurred at the transcrip-
tional level. Transcription of RANTES and IFN-b, which
was the most severely affected by the L protein, is known to
be upregulated by IRF-3 (Schafer et al., 1998; Lin et al.,
1999a). Upon viral infection, IRF-3 is phosphorylated by
TBK-1 and IKK-e kinases. This induces IRF-3 dimerization
and translocation into the nucleus (Yoneyama et al., 1998;
Lin et al., 1999a, b; Fitzgerald et al., 2003; Sharma et al.,
2003) where IRF-3 associates with other transcription
factors and CBP/p300 on specific promoter motifs to
activate cytokine and chemokine gene transcription (Panne
et al., 2007). As recently reported in the case of the EMCV
L protein (Hato et al., 2007), the TMEV L protein inhibited
IRF-3 dimerization in infected cells (Fig. 4). Intriguingly,
IRF-3 dimerization is believed to take place in the cell
cytoplasm and to precede nuclear translocation of this
factor. Thus, whether inhibition of IRF-3 dimerization can
be consequent to nucleocytoplasmic trafficking alteration
deserves further investigation.
Mutation of the zinc finger of the L protein affected all of
the tested activities of this protein. A possible explanation
is that disruption of the zinc finger modified the global fold
of the L protein, thus impacting on the different functions
of this protein. An alternative explanation is that the
various functions of the L protein may be coupled.
It is also interesting to note that not all functions of the L
protein were affected equally by the zinc-finger disruption.
This mutation had a high impact on cytokine gene
transcription inhibition. It also almost fully prevented
Nup98 phosphorylation. Yet, it only partially inhibited
poly(A)+ RNA export from the nucleus (Fig. 2). This raises
the possibility that full inhibition of mRNA export by the L
protein is due to disruption of multiple factors in the
mRNA export pathway. Alternatively, residual activity of
the Lcys mutant might go undetected or become apparent
according to the experimental settings.
In vivo, IFN-a/b is a key component in the defence against
viruses. IFNAR-knockout mice, which are unable to
respond to type I IFN, are extremely sensitive to a large
panel of viruses and notably to TMEV (Fiette et al., 1995).
Here, the importance of the IFN system in the CNS of mice
was confirmed by the fact that survival of IFNAR2/2 mice
was compromised as early as 4 days after intracranial
inoculation and that viral load at this time was impressive
(more than ten copies of viral RNA per copy of b-actin
mRNA in the entire brain). We also tested the importance
of the L protein in the antagonism of the IFN response in
vivo. In IFN-competent mice, an Lcys mutant virus
exhibited less fitness than the wild-type virus. In contrast,
in the IFNAR2/2 mice, the mutant virus replicated at least
as well as the wild-type virus (Fig. 5a). The fact that the Lcys
mutation affected viral yield in wild-type but not in
IFNAR2/2 mice suggests that, in vivo, antagonism of the
IFN system is an important function of the L protein, at
least during the first days of infection. However, in contrast
to the in vitro situation, inhibition of IFN-b mRNA
expression in vivo by the L protein was quite modest. This
difference between the in vitro and the in vivo situations
may be accounted for by the fact that, in vivo, only a small
percentage of the cells is infected. On the one hand, this
allows priming of some cells by IFN or by other cytokines
before the occurrence of their infection by the virus. Such
priming has been shown to override the ability of the L
protein to block IFN production (van Pesch & Michiels,
2003). On the other hand, it has been shown previously
that, in the CNS of mice infected with TMEV or La Crosse
virus, a substantial number of IFN-a/b-producing cells
were negative for viral antigen (Delhaye et al., 2006).
Recent work notably showed that uptake of picornavirus-
infected cells by dendritic cells allows activation of the IFN
system (Kramer et al., 2008). Thus, uninfected cells
probably detect virus replication products released by
infected cells, possibly through Toll-like receptor recog-
nition. As L protein is not expressed in these cells, no
inhibition of IFN production would be expected.
Nevertheless, even if IFN production inhibition in vivo is
low, the importance of the L protein as an IFN antagonist
in vivo is underlined by its influence on virus replication in
wild-type compared with IFNAR2/2 mice. One might also
consider that a small overall reduction in IFN production
could hide more extensive local effects that may be
physiologically relevant.
In conclusion, as with other viral proteins (such as the NS1
protein of influenza virus, M protein of VSV, 2A protein of
poliovirus and L protein of foot-and-mouth disease virus),
the L protein of TMEV may be a multi-functional protein
devoted to antagonizing the cell and the host innate
defences, and in particular the type I IFN response. Two
activities have now been identified for the L protein of
cardioviruses. Firstly, the L protein represses transcription
of virus-induced genes by preventing IRF-3 dimerization.
Secondly, by interacting with Ran GTPase (as shown for
the EMCV L protein) and/or by promoting phosphoryla-
tion of nuclear pore complex proteins (as shown for the
TMEV L protein), L proteins would affect nucleocytoplas-
mic trafficking of proteins and mRNA export, thereby
triggering a late global shut-off of protein expression.
Whether these two activities of the L protein indeed
represent different functions or whether they are connected
remains an open question that clearly deserves further
investigation.
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